Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Mironid
Entity

Mironid

Tracked across 1 events · 7 articles · First seen Aug 05, 2026 · Last active Aug 07, 2026

Sentiment
80
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
2 80
Business
Mironid raises $46M Series B
Mironid, a Glasgow-based biopharmaceutical company developing small molecule therapeutics for Autosomal Dominant Polycystic Kidney Disease (ADPKD), announced on August 5, 2026 that it raised $46 million in a Series B funding round. The round was…
Impact: Mironid is the central entity, raising $46 million to advance its lead ADPKD candidate. This funding boosts its financial position and supports clinical development, enhancing its prospects.
Aug 05, 2026 · 7 articles
Key Actions (7)
100 Mironid raisedMironid raises $46M Series B
80 Scotland — Scottish National Investment Bank invested MironidMironid raises $46M Series B
70 Roche Venture Fund invested MironidMironid raises $46M Series B
70 Epidarex Capital invested MironidMironid raises $46M Series B
70 Sofinnova Partners invested MironidMironid raises $46M Series B
70 BioGeneration Ventures invested MironidMironid raises $46M Series B
60 Mironid completed IND-enabling studiesMironid raises $46M Series B
ERGEN INTELLIGENCE
Track Mironid live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.